Silymarin in the management of liver enzyme activity in steatohepatitis: a case report
Metabolic-associated fatty liver disease (MAFLD) is the main condition of altered liver enzymes worldwide. With a constant increase in liver hospitalizations, MAFLD is the second cause of cirrhosis and soon will be the first cause of liver transplantation. Early recognition of MAFLD and a personaliz...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioExcel Publishing Ltd
2023-04-01
|
| Edice: | Drugs in Context |
| Témata: | |
| On-line přístup: | https://www.drugsincontext.com/silymarin-in-the-management-of-liver-enzyme-activity-in-steatohepatitis-a-case-report/ |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|